QR Code

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison

Abstract Introduction A matching-adjusted indirect comparison evaluated the short-term efficacy of lebrikizumab plus topical corticosteroids (TCS) versus dupilumab plus TCS in adults with moderate-to-severe atopic dermatitis (AD). Methods Individual patient data from the ADhere trial (lebrikizumab 2...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Raj Chovatiya, April Armstrong, Leon Kircik, Lluís Puig, Mark G. Kirchhof, Tiago Torres, Yousef Binamer, Gleison Duarte, Bülent Akmaz, Martin Dossenbach, Gaia Gallo, Chao Yang, Lucia Seminario-Vidal, Yuxin Ding, Jonathan I. Silverberg
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Adis, Springer Healthcare 2025-12-01
Rangatū:Dermatology and Therapy
Ngā marau:
Atopic dermatitis
Combination therapy
Eczema Area and Severity Index
Investigator Global Assessment
Dermatology Life Quality Index
Dupilumab
Urunga tuihono:https://doi.org/10.1007/s13555-025-01620-x
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite